- Home
- AUPH vs MEG Comparison
AUPH vs MEG Comparison
Compare AUPH & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- MEG
- Stock Information
- Founded
- AUPH 1993
- MEG 2012
- Country
- AUPH Canada
- MEG United States
- Employees
- AUPH N/A
- MEG N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- MEG Professional Services
- Sector
- AUPH Health Care
- MEG Consumer Discretionary
- Exchange
- AUPH Nasdaq
- MEG Nasdaq
- Market Cap
- AUPH 1.1B
- MEG 764.0M
- IPO Year
- AUPH 1999
- MEG 2020
- Fundamental
- Price
- AUPH $8.86
- MEG $22.97
- Analyst Decision
- AUPH Strong Buy
- MEG Buy
- Analyst Count
- AUPH 2
- MEG 5
- Target Price
- AUPH $11.50
- MEG $31.80
- AVG Volume (30 Days)
- AUPH 2.0M
- MEG 397.2K
- Earning Date
- AUPH 07-31-2025
- MEG 08-05-2025
- Dividend Yield
- AUPH N/A
- MEG N/A
- EPS Growth
- AUPH N/A
- MEG N/A
- EPS
- AUPH 0.27
- MEG N/A
- Revenue
- AUPH $247,295,000.00
- MEG $718,904,000.00
- Revenue This Year
- AUPH $12.15
- MEG $10.49
- Revenue Next Year
- AUPH $18.31
- MEG $7.06
- P/E Ratio
- AUPH $33.08
- MEG N/A
- Revenue Growth
- AUPH 29.20
- MEG 10.92
- 52 Week Low
- AUPH $5.20
- MEG $10.51
- 52 Week High
- AUPH $10.67
- MEG $40.84
- Technical
- Relative Strength Index (RSI)
- AUPH 64.10
- MEG 58.97
- Support Level
- AUPH $7.36
- MEG $22.60
- Resistance Level
- AUPH $9.10
- MEG $24.06
- Average True Range (ATR)
- AUPH 0.44
- MEG 1.09
- MACD
- AUPH 0.10
- MEG -0.02
- Stochastic Oscillator
- AUPH 89.53
- MEG 69.49
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About MEG Montrose Environmental Group Inc.
Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.